Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed investors and wiped $125 billion from ...

With limited finances and a modest hourly wage from his trucking job, the man had to make a devastating choice: buy his ...

Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit.A new study ...

Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...

After the shooting, the suspect allegedly stole the victim's car and debit card to withdraw more than a thousand dollars to ...

SPARTANBURG, S.C. (FOX Carolina) - The Spartanburg Police Department reports responding to a stabbing incident that left one ...

The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

Three people were arrested on Tuesday after officers seized a stolen firearm and drugs after complaints of drug dealing in ...

Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).

Several law enforcement agencies collaborated during the investigation including the Carrollton Police Department, Carroll ...